Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | Melatonin receptor type 1A | 0.0021 | 0 | 0.5 |
Brugia malayi | Dopamine receptor protein 1 | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0152 | 0.3376 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0152 | 0.3376 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0152 | 0.3376 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | GnHR receptor homolog | 0.0021 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | AKH receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | G protein-coupled receptor F59B2.13 | 0.0021 | 0 | 0.5 |
Brugia malayi | G-protein coupled receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | RE15519p | 0.0021 | 0 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | follicle stimulating hormone receptor | 0.0021 | 0 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0152 | 0.3376 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0152 | 0.3376 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | Dopamine receptor | 0.0021 | 0 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | Dopamine receptor protein 2 | 0.0021 | 0 | 0.5 |
Brugia malayi | neuropeptide F receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.0021 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1006 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | putative neuropeptide receptor NPR1 | 0.0021 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0152 | 0.3376 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.1006 | 1 |
Brugia malayi | Serotonin receptor | 0.0021 | 0 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0152 | 0.3376 | 0.5 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Brugia malayi | Dopamine receptor protein 1, putative (partial) | 0.0021 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | putative neuropeptide receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | G protein-coupled receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | larval opioid receptor | 0.0021 | 0 | 0.5 |
Brugia malayi | G-protein-linked acetylcholine receptor protein 2, putative | 0.0021 | 0 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | sulfakinin receptor protein | 0.0021 | 0 | 0.5 |
Brugia malayi | neuropeptide F receptor | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | ORL1-like opioid receptor | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0 | 0.5 |
Brugia malayi | Serotonin receptor | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | G-protein coupled receptor | 0.0021 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | Tachykinin-like peptides receptor 99D | 0.0021 | 0 | 0.5 |
Brugia malayi | gonadotropin-releasing hormone receptor 2 | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0152 | 0.3376 | 0.5 |
Brugia malayi | Unidentified vitellogenin-linked transcript protein 6, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0152 | 0.3376 | 0.5 |
Onchocerca volvulus | 0.006 | 0.1006 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.